GPCM
TELA icon

Granite Point Capital Management’s TELA Bio TELA Stock Holding History

Granite Point Capital Management’s Portfolio TELA Stock Details TELA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-115,659
Closed -$1.33M – 101
2022
Q4 		$1.33M Sell
115,659
-111,985
-49% -$1M 0.85% 29
2022
Q3 		$1.94M Hold
227,644
– – 0.79% 22
2022
Q2 		$1.6M Hold
227,644
– – 0.41% 29
2022
Q1 		$2.65M Hold
227,644
– – 0.55% 37
2021
Q4 		$2.91M Hold
227,644
– – 0.49% 48
2021
Q3 		$3.11M Buy
227,644
+27,644
+14% +$386K 0.24% 44
2021
Q2 		$3.22M Buy
+200,000
New +$2.74M 0.12% 54

Other funds holding TELA

EWM
Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
NCGI
Next Century Growth Investors Plymouth, Minnesota $1.38B AUM 102.34% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $31.6M AUM 28.5% 1-Year Est. Return
PVI
Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return

Granite Point Capital Management's TELA Position: Q1 2023 in Review

Granite Point Capital Management sold out of TELA Bio (TELA) in Q1 2023, closing a stake of 115,659 shares — an estimated $1.33M sold.

Granite Point Capital Management first reported a position in TELA in Q2 2021 and held it in 7 quarters. The position peaked at $3.22M in Q2 2021. 53 funds tracked by Wall St. Rank hold TELA as of Q1 2023.

  • Granite Point Capital Management reported no remaining TELA Bio position as of Q1 2023 after selling out during the quarter.
  • Granite Point Capital Management sold 115,659 TELA Bio shares in Q1 2023, an estimated $1.33M.
  • Granite Point Capital Management first reported a position in TELA Bio in Q2 2021 and held it in 7 quarters.
  • Granite Point Capital Management's TELA Bio position peaked at $3.22M in Q2 2021.
  • 53 funds tracked by Wall St. Rank held TELA Bio as of Q1 2023.

Based on Granite Point Capital Management's 13F filing for Q1 2023, filed 11 May 2023.